Clinical Trial Update: A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing matured dendritic cells and Montanide in subjects with high risk of melanoma recurrence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Montanide (Montanide adjuvant)
• matured dendritic cells (dendritic cells (matured))

Snippet

Sponsor: Nina Bhardwaj | Conditions: Melanoma | Phase 2 | Status: COMPLETED